3rd Assay Development & Screening Technologies Conference :: International Microencapsulation Society :: Microencapsulation, Microspheres and Microcapsules

Events :: 3rd Assay Development & Screening Technologies Conference :: (1771 Reads)

Posted by raniah@gtcbio.com on Saturday, March 08, 2008 - 09:13 PM

June 5-6, 2008 - San Francisco, CAhttp://gtcbio.com/conferenceDetails.aspx?id=123

GTCbio's 3rd Assay Development and Screening Technologies conference on June 5-6, 2008 in San Francisco, CA will provide attendees with critical information to utilize in the discovery and development of assays, while keeping them informed about the latest screening technologies for both high-throughput screening and high-content screening.

Hear from leading researchers developing and using assays to advance their discovery pipelines. Register today to network with top industry representatives!

Submit an Abstract by May 5, 2008

Register by April 5, 2008 for a 20% DISCOUNT

Program Highlights:

Cell Based Assays Part I - High Throughput Screening
Cell Based Assays Part II - High Content Screening
In Vitro Assays and Screening
Novel Assay and Screening Technologies
Target Validation and Assay Development
Informatics – Data and Sample Collection & Management

Click here for a FULL AGENDA

Register 2, the 3rd person goes free!
Visit www.gtcbio.com or call 626-256-6405 for details.

Keynote Speakers:

Robert Hertzberg, Ph.D.
Vice President, Screening & Compound Profiling
GlaxoSmithKline

Berta Strulovici, Ph.D.
Vice President, Basic Research MRL, Automated Biotechnology Head
Merck & Co.

Christopher P. Austin, Ph.D.
Director, NHGRI;
Senior Advisor for Translational Research, Office of the Director
National Human Genome Research Institute, NIH

Presenting Organizations:

Gautam Agnihotri, New Lead Discovery, Schering-Plough
Jeremy Caldwell, Executive Director, Molecular and Cell Biology
Genomics Institute of the Novartis Research Foundation
John Cuozzo, Director, Lead Discovery, GlaxoSmithKline
Hakim Djaballah, Director, HTS Core Facility Head, Memorial Sloan Kettering Cancer Center
Paul Lang, Head of Assay Development and Biomolecular Pharmacology, Merck Serono Pharmaceutical Research Institute
Yaya Liu, Ph.D., Research Investigator, Abbott Laboratories
David Mark, Head of Screening Technologies, Roche
Y. Gloria Meng, Technology, Genentech
Matthew Olson, Johnson & Johnson
Gary Piazza, Molecular Libraries Screening Center, Southern Research Institute
Clay Scott, Associate Director, Lead Generation Dept., AstraZeneca
Theingi Thway, Ph.D., Pharmacokinetics & Drug Metabolism, Amgen
Hong Xin, Ph.D., Lead Generation, Johnson & Johnson

And more! Click here for a full speakers list.

20% DISCOUNT DEADLINE: April 5, 2008
Abstract Deadline: May 5, 2008. Click here to submit an abstract.

For More information visit www.gtcbio.com or call 626-256-6405.